Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 83, Issue 1-5, 2002, Pages 85-92

  Welsh, JoEllen ^a   Wietzke, Jennifer A ^a   Zinser, Glendon M ^a   Smyczek, Sarah ^a   Romu, Saara ^a   Tribble, Emily ^a   Welsh, Jennifer C ^a   Byrne, Belinda ^a   Narvaez, Carmen J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Breast cancer; Mammary gland; VDR knockout mice; Vitamin D3

Indexed keywords

CALCITRIOL; COLECALCIFEROL; PHYTOESTROGEN; CALCITRIOL RECEPTOR;

APOPTOSIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL TYPE; CONFERENCE PAPER; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; INVOLUTION; MAMMARY GLAND; NONHUMAN; UPREGULATION; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; BREAST; BREAST TUMOR; CELL DIVISION; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIVISION; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; RECEPTORS, CALCITRIOL; UP-REGULATION;

EID: 0037981379     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00277-7     Document Type: Conference Paper

References (35)

1. 3 induces morphological and biochemical indices of apoptosis in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 58:1996;367-376.
2. Narvaez C.J., Welsh J.E. Role of mitochondria and caspases in vitamin D-mediated apoptosis of breast cancer cells. J. Biol. Chem. 276:2001;9101-9107.
3. VanWeelden K., Flanagan L., Binderup L., Tenniswood M., Welsh J.E. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D analog EB1089. Endocrinology. 139:1998;2102-2110.
4. 3 receptor ablation alters mammary gland morphogenesis, Development, in press.
5. 3 receptor content during pregnancy and lactation. Mol. Cell. Endocrinol. 60:1988;15-22.
6. Bhattacharjee M., Wientroub S., Vonderhaar B.K. Milk protein synthesis by mammary glands of vitamin D-deficient mice. Endocrinology. 121:1987;865-874.
7. Mezzetti G., Monti M.G., Pernecco Casolo L., Piccinini G., Moruzzi M.S. 1,25Dihydroxycholecalciferol-dependent calcium uptake by mouse mammary gland in culture. Endocrinology. 122:1988;389-394.
8. 5. J. Natl. Cancer Inst. 89:1997;212-218.
9. Jacobson E., James K., Newmark H., Carroll K. Effects of dietary fat, calcium and vitamin D on growth and mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene in female Sprague-Dawley rats. Cancer Res. 49:1989;6300-6303.
10. 3 and breast cancer risk. Public Health Nutr. 2:1999;283-291.
11. Curran J.E., Vaughn T., Lea R.A., Weinstein S.R., Morrison N.A., Griffiths L.R. Association of a vitamin D receptor polymorphism with sporadic breast cancer development. Int. J. Cancer. 83:1999;723-726.
12. Lundin A.C., Bergmann-Jungestron M., Wingren S. Association of breast cancer progression with a vitamin D receptor polymorphism. Cancer Res. 59:1999;2332-2334.
13. Ingles S.A., Garcia D.G., Wang W., Nieters A., Henderson B.E., Coetzee G.A. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control. 11:2000;25-30.
14. Bretherton-Watt D., Given-Wilson R., Mansi J.L., Thomas V., Carter N., Colston K.W. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br. J. Cancer. 85:2001;171-176.
15. 3 in mammary gland: from normal development to breast cancer. Steroids. 66:2001;301-308.
16. 3 on the G1-S phase controlling machinery. Mol. Endocrinol. 15:2001;1370-1380.
17. Colston K.W., Mork Hansen C. Mechanisms implicated in the growth-regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer. 9:2001;45-59.
18. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9831-9835.
19. Li Y.C., Amling M., Pirro A.E., Priemel M., Meuse J., Baron R., Delling G., Demay M.B. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets and osteomalacia, but not alopecia, in vitamin D receptor ablated mice. Endocrinology. 139:1998;4391-4396.
20. Johnson L.E., DeLuca H.F. Vitamin D receptor null mice fed high levels of calcium are fertile. J. Nutr. 131:2001;1787-1791.
21. Mathiasen I.S., Lademann U., Jaattela M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res. 59:1999;4848-4856.
22. Powis G., Mustacich D., Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29:2000;312-322.
23. 3 resistant MCF-7 cell line. Endocrinology. 137:1996;400-409.
24. Koren R., Hadari-Naor I., Zuck E., Rotem C., Liberman U.A., Ravid A. Vitamin D is a pro-oxidant in breast cancer cells. Cancer Res. 61:2001;1439-1444.
25. Chen K.S., DeLuca H.F. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta. 1219:1994;26-32.
26. Yang X., Young L.H., Voigt J.M. Expression of a vitamin D regulated gene (VDUP-1) in untreated and MNU-treated rat mammary tissue. Breast Cancer Res. Treat. 48:1998;33-44.
27. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274:1999;21645-21650.
28. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK)1. EMBO J. 17:1998;2596-2606.
29. R: a new vitamin D resistant cell line. J. Cell. Biochem. 84:2001;422-436.
30. Norman A.W., Silva F.R. Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system. Rev. Endocr. Metab. Disord. 2:2001;229-238.
31. 3. Steroids. 67:2002;457-466.
32. 3 receptors in breast cancer and relationship to biochemical and clinical indices. Cancer Res. 46:1984;1677-1681.
33. 3 receptor in primary breast cancers. Cancer Res. 46:1986;5406-5408.
34. Smith C.L. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod. 58:1998;627-632.
35. Byrne I., Flanagan L., Tenniswood M., Welsh J.E. Identification of a hormone responsive promoter upstream of exon 1c in the human vitamin D receptor gene. Endocrinology. 141:2000;2829-2836.